Pasithea Therapeutics Corp. financial data

Symbol
KTTA, KTTAW on Nasdaq
Industry
Pharmaceutical Preparations
Location
2110 Narcissus Ct, Venice, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 675 % -51%
Debt-to-equity 9.78 % +36.4%
Return On Equity -81.7 % -85.4%
Return On Assets -74.4 % -81%
Operating Margin -2.59K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.27M shares -93.9%
Common Stock, Shares, Outstanding 1.04M shares -95%
Entity Public Float 10.5M USD -45.9%
Common Stock, Value, Issued 104 USD -99.4%
Weighted Average Number of Shares Outstanding, Basic 1.04M shares -17%
Weighted Average Number of Shares Outstanding, Diluted 1.04M shares -17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 487K USD
Research and Development Expense 9.04M USD -2.67%
General and Administrative Expense 1.42M USD -34.2%
Operating Income (Loss) -16.1M USD -8.51%
Nonoperating Income (Expense) 4.77K USD -97.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.8M USD -8.45%
Net Income (Loss) Attributable to Parent -15.8M USD +1.6%
Earnings Per Share, Basic -0.42 USD/shares +76.1%
Earnings Per Share, Diluted -0.42 USD/shares +76.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.36M USD -52.2%
Other Assets, Current 98.3K USD -7.68%
Assets, Current 9.78M USD -52.9%
Property, Plant and Equipment, Net 127K USD -12.9%
Operating Lease, Right-of-Use Asset 32K USD -93%
Intangible Assets, Net (Excluding Goodwill) 7.47M USD
Goodwill 1.26M USD 0%
Other Assets, Noncurrent 46.6K USD
Assets 18.6M USD -39.2%
Liabilities, Current 660K USD -67.7%
Operating Lease, Liability, Noncurrent 211K USD -70.9%
Liabilities 824K USD -63.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -35.3K USD -358%
Retained Earnings (Accumulated Deficit) -46.4M USD -53.3%
Stockholders' Equity Attributable to Parent 17.8M USD -37.2%
Liabilities and Equity 18.6M USD -39.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.53M USD -562%
Net Cash Provided by (Used in) Financing Activities 264K USD
Net Cash Provided by (Used in) Investing Activities -114K USD
Common Stock, Shares Authorized 100M shares -79.8%
Common Stock, Shares, Issued 1.04M shares -95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.32M USD -36.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.36M USD -52.2%
Deferred Tax Assets, Valuation Allowance 4.14M USD +345%
Deferred Tax Assets, Gross 7.64M USD +83.9%
Operating Lease, Liability 33K USD -92.9%
Depreciation 4.72K USD +12.9%
Payments to Acquire Property, Plant, and Equipment 53.9K USD +2662%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.8M USD -10.3%
Lessee, Operating Lease, Liability, to be Paid 33.3K USD
Property, Plant and Equipment, Gross 165K USD 0%
Operating Lease, Liability, Current 33K USD -80%
Lessee, Operating Lease, Liability, to be Paid, Year Two 183K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 83.3K USD -72%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 323 USD -99.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 183K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 116K USD
Additional Paid in Capital 64.3M USD +9.58%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 7.61M USD +83.8%
Share-based Payment Arrangement, Expense 176K USD +18.6%
Operating Leases, Future Minimum Payments Due 83.3K USD
Interest Expense -117K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%